Samarjit Singh promoted to New Director of Clinical Operations

Richmond Pharmacology is delighted to announce the promotion of Samarjit Singh into the position of Director of Clinical Operations.

Samarjit has been part of the Richmond Pharmacology team for more than 16 years, during which he held several positions, including his most recent as Head of Scheduling.

In his new role, Samarjit will bring his years of industry experience and knowledge to drive best practice in (non-medical) clinical operations execution across the company, setting strategic guidance for the clinical operations teams and providing operational direction for the delivery of clinical trials undertaken at Richmond Pharmacology.

The position of Director of Clinical Operations has been developed to reflect the planned growth strategy of Richmond Pharmacology.

On his promotion, Samarjit said: “I’m excited about the opportunity to elevate clinical operations to the next level within Richmond Pharmacology.”

Richmond Pharmacology is a full-service clinical research organisation based in London, UK. Founded in 2001, Richmond Pharmacology is led by its founding directors Dr Jorg Taubel, CEO and Dr Ulrike Lorch, whose experience has been gained in more than 500 clinical trials.